A. Mueller, N. G. Mahmoud, and P. G. Strange, Diverse signalling by different chemokines through the chemokine receptor CCR5, Biochemical Pharmacology, vol.72, issue.6, pp.739-748, 2006.
DOI : 10.1016/j.bcp.2006.06.001

G. Alkhatib, C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy et al., CC CKR5: A RANTES, MIP-1??, MIP-1 Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1, Science, vol.272, issue.5270, pp.1955-1958, 1996.
DOI : 10.1126/science.272.5270.1955

M. Samson, F. Libert, B. J. Doranz, J. Rucker, C. Liesnard et al., Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature, vol.382, issue.6593, pp.722-725, 1996.
DOI : 10.1038/382722a0

N. Ray, Maraviroc in the treatment of HIV infection, Drug Design, Development and Therapy, vol.2, pp.151-161, 2009.
DOI : 10.2147/DDDT.S3474

A. A. Haqqani and J. C. Tilton, Entry inhibitors and their use in the treatment of HIV-1 infection, Antiviral Research, vol.98, issue.2, pp.158-170, 2013.
DOI : 10.1016/j.antiviral.2013.03.017

R. Nygaard, Y. Zou, R. O. Dror, T. J. Mildorf, D. H. Arlow et al., The Dynamic Process of ??2-Adrenergic Receptor Activation, Cell, vol.152, issue.3, pp.532-542, 2013.
DOI : 10.1016/j.cell.2013.01.008

A. W. Kahsai, K. Xiao, S. Rajagopal, S. Ahn, A. K. Shukla et al., Multiple ligand-specific conformations of the ??2-adrenergic receptor, Nature Chemical Biology, vol.220, issue.10, pp.692-700, 2011.
DOI : 10.1038/nchembio.634

M. Oppermann, Chemokine receptor CCR5: insights into structure, function, and regulation, Cellular Signalling, vol.16, issue.11, pp.1201-1210, 2004.
DOI : 10.1016/j.cellsig.2004.04.007

B. Lagane, S. Ballet, T. Planchenault, K. Balabanian, L. Poul et al., Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis, Molecular Pharmacology, vol.67, issue.6, pp.1966-1976, 2005.
DOI : 10.1124/mol.104.009779

R. Berro, P. J. Klasse, D. Lascano, A. Flegler, K. A. Nagashima et al., Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors, Journal of Virology, vol.85, issue.16, pp.8227-8240, 2011.
DOI : 10.1128/JVI.00767-11

P. Colin, Y. Benureau, I. Staropoli, Y. Wang, N. Gonzalez et al., HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines, Proceedings of the National Academy of Sciences, vol.110, issue.23, pp.9475-9480, 2013.
DOI : 10.1073/pnas.1222205110
URL : https://hal.archives-ouvertes.fr/pasteur-00825629

R. Berro, A. Yasmeen, R. Abrol, B. Trzaskowski, S. Abi-habib et al., Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants, Journal of Virology, vol.87, issue.12, pp.6569-6581, 2013.
DOI : 10.1128/JVI.00099-13

O. Hartley, H. Gaertner, J. Wilken, D. Thompson, R. Fish et al., Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors, Proceedings of the National Academy of Sciences, vol.101, issue.47, pp.16460-16465, 2004.
DOI : 10.1073/pnas.0404802101

C. Pastore, G. R. Picchio, F. Galimi, R. Fish, O. Hartley et al., Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES, Antimicrobial Agents and Chemotherapy, vol.47, issue.2, pp.509-517, 2003.
DOI : 10.1128/AAC.47.2.509-517.2003

M. M. Lederman, R. S. Veazey, R. Offord, D. E. Mosier, J. Dufour et al., Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5, Science, vol.306, issue.5695, pp.485-487, 2004.
DOI : 10.1126/science.1099288

H. Gaertner, O. Lebeau, I. Borlat, F. Cerini, B. Dufour et al., Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1??/CCL4, Protein Engineering Design and Selection, vol.21, issue.2, pp.65-72, 2008.
DOI : 10.1093/protein/gzm079

J. M. Escola, G. Kuenzi, H. Gaertner, M. Foti, H. et al., CC Chemokine Receptor 5 (CCR5) Desensitization: CYCLING RECEPTORS ACCUMULATE IN THE TRANS-GOLGI NETWORK, Journal of Biological Chemistry, vol.285, issue.53, pp.41772-41780, 2010.
DOI : 10.1074/jbc.M110.153460

A. Benmerah, M. Bayrou, N. Cerf-bensussan, and A. Varsat, Inhibition of clathrin-coated pit assembly by an Eps15 mutant, J Cell Sci, vol.112, pp.1303-1311, 1999.

H. Issafras, S. Angers, S. Bulenger, C. Blanpain, M. Parmentier et al., Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors, Journal of Biological Chemistry, vol.277, issue.38, pp.34666-34673, 2002.
DOI : 10.1074/jbc.M202386200

H. Storez, M. G. Scott, H. Issafras, A. Burtey, A. Benmerah et al., Homo- and Hetero-oligomerization of ??-Arrestins in Living Cells, Journal of Biological Chemistry, vol.280, issue.48, pp.40210-40215, 2005.
DOI : 10.1074/jbc.M508001200
URL : https://hal.archives-ouvertes.fr/hal-00015674

A. Molla-herman, C. Boularan, R. Ghossoub, M. G. Scott, A. Burtey et al., Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity, PLoS One Proc Natl Acad Sci, vol.3, issue.96, pp.5698-5703, 1999.

H. Gaertner, F. Cerini, J. M. Escola, G. Kuenzi, A. Melotti et al., Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide, Proceedings of the National Academy of Sciences, vol.105, issue.46, pp.17706-17711, 2008.
DOI : 10.1073/pnas.0805098105

M. Delhaye, A. Gravot, D. Ayinde, F. Niedergang, M. Alizon et al., Identification of a Postendocytic Sorting Sequence in CCR5, Molecular Pharmacology, vol.72, issue.6, pp.1497-1507, 2007.
DOI : 10.1124/mol.107.038422

M. Cavrois, C. De-noronha, and W. C. Greene, A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes, Nature Biotechnology, vol.20, issue.11, pp.1151-1154, 2002.
DOI : 10.1038/nbt745

C. Randriamampita, G. Boulla, P. Revy, F. Lemaitre, and A. Trautmann, T???cell adhesion lowers the threshold for antigen detection, European Journal of Immunology, vol.33, issue.5, pp.1215-1223, 2003.
DOI : 10.1002/eji.200323844

C. Conche, G. Boulla, A. Trautmann, R. , and C. , T Cell Adhesion Primes Antigen Receptor-Induced Calcium Responses through a Transient Rise in Adenosine 3???,5???-Cyclic Monophosphate, Immunity, vol.30, issue.1, pp.33-43, 2009.
DOI : 10.1016/j.immuni.2008.10.020

L. Achour, M. Kamal, R. Jockers, and S. Marullo, Using Quantitative BRET to Assess G Protein-Coupled Receptor Homo- and Heterodimerization, Methods Mol Biol, vol.756, pp.183-200, 2011.
DOI : 10.1007/978-1-61779-160-4_9

C. Basquin, V. Malarde, P. Mellor, D. H. Anderson, V. Meas-yedid et al., The signalling factor PI3K is a specific regulator of the clathrin-independent dynamin-dependent endocytosis of IL-2 receptors, Journal of Cell Science, vol.126, issue.5, pp.1099-1108, 2013.
DOI : 10.1242/jcs.110932

C. Watson, S. Jenkinson, W. Kazmierski, and T. Kenakin, The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry Inhibitor, Molecular Pharmacology, vol.67, issue.4, pp.1268-1282, 2005.
DOI : 10.1124/mol.104.008565

O. B. Goodman, . Jr, J. G. Krupnick, F. Santini, V. V. Gurevich et al., ??-Arrestin acts as a clathrin adaptor in endocytosis of the ??2-adrenergic receptor, Nature, vol.383, issue.6599, pp.447-450, 1996.
DOI : 10.1038/383447a0

T. Diez, L. Bonsch, C. Malkusch, S. Truan, Z. Munteanu et al., Coordinate-based co-localization-mediated analysis of arrestin clustering upon stimulation of the C-C chemokine receptor 5 with RANTES/CCL5 analogues Total internal reflection fluorescence (TIRF) microscopy, Histochem Cell Biol Fish, K. N. Curr Protoc Cytom Chapter, vol.33, pp.12-18, 2009.

L. Jacquin, F. Franceschi, Y. By, J. M. Durand-gorde, J. Condo et al., spare receptors on peripheral human lymphocytes, FEBS Open Bio, vol.25, issue.4, pp.1-5, 2013.
DOI : 10.1016/j.fob.2012.11.004

S. Rajagopal, D. L. Bassoni, J. J. Campbell, N. P. Gerard, C. Gerard et al., Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors, Journal of Biological Chemistry, vol.288, issue.49, pp.35039-35048, 2013.
DOI : 10.1074/jbc.M113.479113

C. Blanpain, B. J. Doranz, A. Bondue, C. Govaerts, A. De-leener et al., The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle, Journal of Biological Chemistry, vol.278, issue.7, pp.5179-5187, 2003.
DOI : 10.1074/jbc.M205684200

T. Nakajima, G. Kaur, N. Mehra, and A. Kimura, HIV-1/AIDS susceptibility and copy number variation in <i>CCL3L1</i>, a gene encoding a natural ligand for HIV-1 co-receptor CCR5, Cytogenetic and Genome Research, vol.123, issue.1-4, pp.156-160, 2008.
DOI : 10.1159/000184703

D. Schols, P. Proost, S. Struyf, A. Wuyts, I. De-meester et al., CD26-processed RANTES(3???68), but not intact RANTES, has potent anti-HIV-1 activity, Antiviral Research, vol.39, issue.3, pp.175-187, 1998.
DOI : 10.1016/S0166-3542(98)00039-4

W. T. Choi, R. Nedellec, M. Coetzer, P. Colin, B. Lagane et al., CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity, CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity, pp.10218-10220, 2012.
DOI : 10.1128/JVI.00353-12
URL : https://hal.archives-ouvertes.fr/pasteur-00731737

R. Abrol, S. K. Kim, J. K. Bray, B. Trzaskowski, G. et al., Conformational Ensemble View of G Protein-Coupled Receptors and the Effect of Mutations and Ligand Binding, Methods Enzymol, vol.520, pp.31-48, 2013.
DOI : 10.1016/B978-0-12-391861-1.00002-2

R. H. Oakley, S. A. Laporte, J. A. Holt, M. G. Caron, and L. S. Barak, Differential Affinities of Visual Arrestin, beta Arrestin1, and beta Arrestin2 for G Protein-coupled Receptors Delineate Two Major Classes of Receptors, Journal of Biological Chemistry, vol.275, issue.22, pp.17201-17210, 2000.
DOI : 10.1074/jbc.M910348199

J. Barretina, J. Blanco, A. Gutierrez, L. Puig, C. Altisent et al., Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives, Transfusion, vol.14, issue.4, pp.461-467, 2000.
DOI : 10.1089/088922299311277

G. Simmons, P. R. Clapham, L. Picard, R. E. Offord, M. M. Rosenkilde et al., Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist, Science, vol.276, issue.5310, pp.276-279, 1997.
DOI : 10.1126/science.276.5310.276

M. Chabre, P. Deterre, and B. Antonny, The apparent cooperativity of some GPCRs does not necessarily imply dimerization, Trends in Pharmacological Sciences, vol.30, issue.4, pp.182-187, 2009.
DOI : 10.1016/j.tips.2009.01.003
URL : https://hal.archives-ouvertes.fr/hal-00418736

S. E. Kuhmann, E. J. Platt, S. L. Kozak, and D. Kabat, Cooperation of Multiple CCR5 Coreceptors Is Required for Infections by Human Immunodeficiency Virus Type 1, Journal of Virology, vol.74, issue.15, pp.7005-7015, 2000.
DOI : 10.1128/JVI.74.15.7005-7015.2000

D. C. Footnotes-independent-experiments, on HEK293 cells stably expressing "arr2-GFP and FLAG-CCR5 obtained 5, 10 and 15 min after stimulation with 2 nM CCL5 or PSC-RANTES. C, "arr2 spots were detected on TIRF images. Scale bar: 5µm. D, Quantification of the spots over time using the ICY software (mean±s.d; n!10 cells). **p<0